FDA Physician Survey Would Collect Info On Risk Communications
This article was originally published in The Pink Sheet Daily
Executive Summary
Proposed survey seeks to understand when and how physicians like to receive risk information about drug products.
You may also be interested in...
Drug Safety Bulletin Being Considered By FDA
The effort would be overseen by new Associate Center Director for Safety Policy & Communication Paul Seligman.
Janssen US Net Drug Prices Declined 5.7% in 2020; J&J Pushes Rebate Reform
Janssen's net drug prices declined for the fourth year in a row in 2020, while list prices increased 3.8%, according to the company's drug pricing report.
Regeneron COVID-19 Antibody Poised To Add Prevention Claim, Sub-Q Formula
The company is requesting FDA expand the antibody cocktail to include a COVID prevention claim with a lower 1,200mg dose and a subcutaneously administered formula.